A hypoxic microenvironment regulates the proliferation and survival of CML LSCs via hypoxia-inducible factor 1 (HIF-1) and reprograms cancer metabolism through activation of genes involved in glucose transport and glycolytic enzymes. This evidence concerns the gene HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive.